Statistics for Elite Pharmaceuticals, (id:11452 ELTP)

Valuation metrics

Market cap

708.48M

Enterprise value

713.11M

Trailing P/E (ttm)

33.16

Forward P/E

PEG ratio

Price/Sales (ttm)

12.51

Price/Book (mrq)

12.28

Enterprise Value/Revenue

12.59

Enterprise Value/EBITDA

109.07

Overview

Shares outstanding

1.07B

Float

831.02M

Shares short

757.07K

% Held by insiders

0.22%

% Held by institutions

0.00%

Average volume (10 days)

2.40M

Average volume (90 days)

Price summary

52-Week low

0.12

52-Week high

0.75

52-Week change

74.10%

Beta

0.17

50-Day moving average

0.46

200-Day moving average

0.24

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

March 31th, 2024

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

46.55%

Operating margin

1.86%

Operational effectiveness

Return on assets

24.04%

Return on equity

34.92%

Income statement

Revenue (ttm)

0.06

Revenue per share (ttm)

0.06

Quarterly revenue growth (yoy)

-0.46

Gross profit (ttm)

26.36M

EBITDA

9.04M

Net income to common (ttm)

20.11M

Diluted EPS (ttm)

0.02

Quarterly earnings growth (yoy)

-46.10%

Balance sheet

Total cash (mrq)

8.41M

Total cash per share (mrq)

0.01

Total debt (mrq)

11.66M

Total Debt/Equity (mrq)

0.20

Current ratio (mrq)

307.97%

Book value per share (mrq)

0.05

Cash flow

Cash flow statement

-9,746,658.00

Levered free cash flow (LFCF)

23.50M